Business Context and Reporting Period
This Form 8-K Current Report was filed by Herbalife Ltd. on April 4, 2008. The filing discloses an amendment to the employment agreement of Gregory L. Probert, President and Chief Operating Officer of Herbalife International of America, Inc., a subsidiary of Herbalife Ltd.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation adjustments.
Material Changes
On April 4, 2008, the Company amended Mr. Probert's employment agreement to modify salary, bonus, and equity terms:
- Salary: Set at a fixed annual amount of $960,000. Future increases to the CEO's salary will no longer impact Mr. Probert's compensation.
- Bonus: Annual target bonus set at 125% of base salary, with a maximum potential of 250% based on targets set by the Compensation Committee.
- Equity Awards:
- Restricted Stock Units (RSUs): Grant of 81,550 RSUs. Vesting schedule: 30% annually on April 4, 2009, 2010, and 2011; remaining 10% on April 4, 2012.
- Stock Appreciation Rights (SARs): Grant covering 290,740 shares with a base price of $50.00. Vesting is contingent on performance targets and continued employment through April 4, 2012.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or general risk factors. Specific contingencies related to the equity awards include:
- Performance Targets for SARs:
- 139,160 SARs vest if the stock price exceeds $67.33 for 30 consecutive trading days prior to April 4, 2012.
- 151,580 SARs vest if the stock price exceeds $80.43 for 30 consecutive trading days prior to April 4, 2012.
- Acceleration Clauses: Full vesting acceleration occurs upon a Change of Control, death, or disability. Partial acceleration applies if employment is terminated without Cause or for Good Reason, subject to alternate price performance targets ($55.64 and $60.82 respectively).
- Termination: SARs generally terminate on April 4, 2015.
Investor Verification Checklist
- Verify the total number of shares underlying the new equity grants (81,550 RSUs and 290,740 SARs).
- Confirm the specific performance metrics required for the Compensation Committee to award the maximum 250% bonus.
- Review the full text of Exhibits 10.1 through 10.4 for detailed vesting conditions and termination provisions.
- Monitor the stock price relative to the $67.33 and $80.43 thresholds to assess the likelihood of SAR vesting.